| Dr Deepa Kuchelan, MD | |
|
1 Guthrie Sq, Sayre, PA 18840-1625 | |
| (570) 888-5858 | |
| (570) 887-2508 |
| Full Name | Dr Deepa Kuchelan |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1 Guthrie Sq, Sayre, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811966765 | NPI | - | NPPES |
| 1013438990001 | Medicaid | PA | |
| 02678779 | Medicaid | NY | |
| CC9269 | Other | PA | RR MEDICARE GROUP |
| GU039812 | Other | PA | MEDICARE GROUP |
| P00240756 | Other | PA | RR MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MD427160 (Pennsylvania) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD427160 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deepa Kuchelan, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 | Dr Deepa Kuchelan, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 |
News Archive
Thirteen drug companies, the governments of the United States, Britain and the United Arab Emirates, the World Bank, the Bill and Melinda Gates Foundation, the Lions Club and other smaller charitable organizations on Monday announced a joint effort to tackle 10 neglected tropical diseases in a coordinated fashion.
While considered a delicacy in some parts of the world, snails have found a more intriguing use to scientists and the medical profession offering a plethora of research possibilities. Cone snails are marine mollusks, just as conch, octopi and squid, but they capture their prey using venom.
In Mexico, 21.7 percent of the population smokes, which is associated with 95 percent of 
lung cancer cases and the development of 29 more different conditions.
Drug discovery and development company Esperance Pharmaceuticals today presented positive results from their preclinical EP-302 program that support the initiation of IND enabling studies. EP-302 is a targeted membrane-disrupting peptide designed to selectively kill cells that express nucleolin on their surface. Nucleolin is a protein that is over-expressed in a wide range of cancers and tumor endothelial cells.
› Verified 5 days ago
Sahzene Yavuz, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 105 Desmond St, Sayre, PA 18840 Phone: 201-421-9520 | |
Dr. Premjeet Singh Dhillon, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-6666 | |
Dr. Michael Jon Depersis, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Square, Guthrie Medical Group, Sayre, PA 18840 Phone: 570-888-5858 | |
Dr. Joseph B. Blood, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-2694 | |
Vishwa Kundoor, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-867-0962 | |
Dr. Jason Paul Kartis, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq Ste B, Sayre, PA 18840 Phone: 570-888-6666 | |
Dr. Victor Olaolu Kolade, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 |